MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash, restricted
cash, and cash...
$857,489
Prepaid expenses and
other current assets
$716,909
Total current assets
$1,574,398
Operating lease
right-of-use assets
$446,263
Property and equipment,
net
$184,449
Total assets
$2,205,110
Accumulated deficit
-$96,724,029
Stock subscription
receivable
$44,545
Total liabilities and
stockholders deficit
$2,205,110
Total stockholders
deficit
-$9,258,755
Additional paid-in capital
$80,288,145
Preferred stock, par value
0.0001 authorized...
$4,002,333
Preferred stock, par value
0.0001 authorized...
$1,926,133
Preferred stock, par value
0.0001 authorized...
$1,287,315
Class a common stock
0.0001 par value...
$3,601
Preferred stock, par value
0.0001 authorized...
$2,292
Total liabilities
$11,463,865
Total current
liabilities
$11,327,100
Convertible notes payable,
net
$136,765
Accounts payable
$7,686,681
Derivative liabilities
$2,396,722
Accrued liabilities
$500,788
Operating lease liability
$461,580
Insurance payable
$195,329
Deemed dividend common
stock liability, 692...
$85,500
Earnout liability
$500
Back
Back
Balance Sheet
CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CERO THERAPEUTICS HOLDINGS, INC. (CERO)
source: myfinsight.com